Search Results

You are looking at 1 - 10 of 308 items for :

  • "rearrangements" x
Clear All
Free access

Trisha Dwight, Aidan Flynn, Kaushalya Amarasinghe, Diana E Benn, Richard Lupat, Jason Li, Daniel L Cameron, Annette Hogg, Shiva Balachander, Ida L M Candiloro, Stephen Q Wong, Bruce G Robinson, Anthony T Papenfuss, Anthony J Gill, Alexander Dobrovic, Rodney J Hicks, Roderick J Clifton-Bligh and Richard W Tothill

)), suggestive of another mechanism of TERT activation. Recently, activation of TERT as a result of structural rearrangements, leading to the placement of enhancers proximal to the TERT promoter have been described in a number of cancer types ( Davis et al

Free access

Gahee Park, Tae Hyuk Kim, Hae-Ock Lee, Jung Ah Lim, Jae-Kyung Won, Hye Sook Min, Kyu Eun Lee, Do Joon Park, Young Joo Park and Woong-Yang Park

:// ; accessed 26th April 2014). Identification of the mutations driving DTC prompted the therapeutic use of oral multikinase inhibitors such as sorafenib, which targets rearranged during transfection (RET), v-raf murine sarcoma viral oncogene homolog B (BRAF

Free access

Kristian Unger, Johannes Wienberg, Andrew Riches, Ludwig Hieber, Axel Walch, Andreas Brown, Patricia C M O'Brien, Cäcilia Briscoe, Lindsey Gray, Elke Rodriguez, Gerhard Jackl, Jeroen Knijnenburg, Giovanni Tallini, Malcolm Ferguson-Smith and Horst Zitzelsberger

Introduction Chromosome rearrangement is a key mechanism for gene alteration and subsequent deregulation of cellular processes such as proliferation, apoptosis, genome stability, angiogenesis and motility, leading to malignant tumour

Free access

Raffaele Ciampi, Thomas J Giordano, Kathryn Wikenheiser-Brokamp, Ronald J Koenig and Yuri E Nikiforov

(reviewed in Ciampi & Nikiforov 2005 , Xing 2005 ). Recently, BRAF has also been shown to be activated in papillary carcinomas by chromosomal rearrangement resulting in the AKAP9-BRAF fusion ( Ciampi et al. 2005 ). It is a rare event in sporadic

Free access

Viktoria Evdokimova, Manoj Gandhi, Jayanagendra Rayapureddi, James R Stringer and Yuri E Nikiforov

higher doses ( Ron et al . 1995 , Cardis et al . 2005 a , b ). Over the last decade, strong evidence has been accumulated supporting the central role of chromosomal rearrangements in carcinogenesis initiated by IR ( Ciampi et al . 2005 , Gandhi et

Free access

Stéphanie Durand, Carole Ferraro-Peyret, Mireille Joufre, Annie Chave, Françoise Borson-Chazot, Samia Selmi-Ruby and Bernard Rousset

Introduction Papillary thyroid carcinomas (PTC), the most common forms of thyroid cancer, are characterized by two main gene alterations, either a rearrangement of RET gene or a point mutation of BRAF gene. As the result of a somatic chromosomal

Free access

Cristina Romei, Raffaele Ciampi, Pinuccia Faviana, Laura Agate, Eleonora Molinaro, Valeria Bottici, Fulvio Basolo, Paolo Miccoli, Furio Pacini, Aldo Pinchera and Rossella Elisei

not responsive to conventional 131-Iodine radiotherapy ( Haugen 1999 ). RET gene rearrangements, BRAF and RAS oncogene point mutations, which can activate the mitogen-activated protein (MAP) kinase signaling pathway, have been highly studied in PTC and

Free access

J Lado-Abeal, R Celestino, S B Bravo, M E R Garcia-Rendueles, J de la Calzada, I Castro, P Castro, C Espadinha, F Palos, P Soares, C V Alvarez, M Sobrinho-Simões and J Cameselle-Teijeiro

proliferator-activated receptor gamma ( PPAR γ ) rearrangement ( Kroll et al . 2005 ) is highly prevalent in follicular thyroid carcinoma (FTC), correlating with an angioinvasive phenotype ( Marques et al . 2002 , Nikiforova et al . 2002 ). PAX8 – PPAR γ

Free access

J Di Cristofaro, V Vasko, V Savchenko, S Cherenko, A Larin, M D Ringel, M Saji, M Marcy, J F Henry, P Carayon and C De Micco

found among liquidators exposed during recovery work from April to July 1986, when the risk of internal irradiation of the thyroid with incorporated 131 I was greatest. Occurrence of ret oncogene rearrangements involving several different

Free access

Giovanna Maria Pierantoni, Palma Finelli, Emanuele Valtorta, Daniela Giardino, Ornella Rodeschini, Francesco Esposito, Marco Losa, Alfredo Fusco and Lidia Larizza

et al. 1994 ). HMGA proteins play a crucial role in the process of cancerogenesis. In fact, chromosomal translocations of 12q13-15, involving the HMGA2 gene, leading to rearrangements and dysregulated expression of the HMGA2 gene, have been